Cerdelga for Gaucher disease type 1
Quick answer: Cerdelga is used for Gaucher disease type 1 as part of a glucosylceramide synthase inhibitor treatment regimen. Eliglustat inhibits glucosylceramide synthase, reducing substrate accumulation in Gaucher disease (substrate reduction therapy) The specific dosing for Gaucher disease type 1 is determined by your prescriber based on individual factors.
Why is Cerdelga used for Gaucher disease type 1?
Cerdelga belongs to the Glucosylceramide synthase inhibitor class. Eliglustat inhibits glucosylceramide synthase, reducing substrate accumulation in Gaucher disease (substrate reduction therapy) This action makes it useful for treating or managing Gaucher disease type 1 in patients for whom this approach is clinically appropriate.
It is one of several treatment options. Whether Cerdelga is the right choice for a specific patient depends on the type and severity of Gaucher disease type 1, response to previous treatments, individual risk factors, and clinical guidelines.
Typical dosing for Gaucher disease type 1
Common adult dosing range: 84 mg once or twice daily based on CYP2D6 metabolizer status. The actual dose for Gaucher disease type 1 depends on:
- Severity of the condition
- Patient's age, weight, and organ function
- Other medications being taken
- Treatment response and tolerability
For complete dosing details, see the Cerdelga medicine page.
What to expect
Cerdelga treatment for Gaucher disease type 1 typically involves:
- Onset of effect: varies by indication and dose — some effects are immediate, others take days to weeks
- Treatment duration: some courses are short-term, others are long-term or lifelong depending on Gaucher disease type 1
- Monitoring: follow-up visits to assess response and adjust dosing
- Side-effect awareness: learning what to expect and what warrants medical attention
Alternatives to consider
If Cerdelga is not appropriate or not tolerated, alternatives within the same class or different therapeutic classes may be considered. See all Glucosylceramide synthase inhibitor for related options.
When to talk to your doctor
Discuss with your prescriber if you experience:
- Inadequate symptom control on Cerdelga
- Side effects affecting daily life
- New medications or supplements that may interact
- Pregnancy planning or pregnancy
- Major changes in health status
Related information
Cerdelga full prescribing information · All Glucosylceramide synthase inhibitor alternatives
Frequently asked questions
How effective is Cerdelga for Gaucher disease type 1?
Effectiveness varies by individual response, dose, and severity. Cerdelga is one of several treatment options for Gaucher disease type 1, supported by clinical evidence within the glucosylceramide synthase inhibitor class. Discuss expected response with your prescriber.
How long do I need to take Cerdelga for Gaucher disease type 1?
Treatment duration depends on the nature of Gaucher disease type 1 — some treatments are short-term, others long-term or lifelong. Never stop on your own; discontinuation requires clinical guidance to avoid relapse or rebound effects.
What are the main side effects of Cerdelga when used for Gaucher disease type 1?
Common and serious side effects are class-related and substance-specific. See the full medicine page for the complete profile. Report any unexpected effects to your prescriber.
Are there alternatives to Cerdelga for Gaucher disease type 1?
Yes. Multiple medicines and non-drug options exist for Gaucher disease type 1. Alternatives within the glucosylceramide synthase inhibitor class share mechanisms; other classes may offer different approaches. Discuss with your clinician.
Last reviewed: by iMedic Medical Editorial Team. Our editorial process.